Apolipoprotein C-II - Wikipedia
Apolipoprotein C-II (Apo-CII, or Apoc-II), or apolipoprotein C2 is a protein that in humans is encoded by the APOC2 gene. The protein encoded by this gene is secreted in plasma, where …
APOC2 Gene - GeneCards | APOC2 Protein | APOC2 Antibody
2024年12月24日 · APOC2 (Apolipoprotein C2) is a Protein Coding gene. Diseases associated with APOC2 include Apolipoprotein C-Ii Deficiency and Familial Apolipoprotein C-Ii Deficiency. …
Role of ApoCs in Lipoprotein Metabolism | Arteriosclerosis, …
1999年3月1日 · ApoC2 is an important activator of LPL and is required for efficient lipolysis of TG-rich lipoproteins in the circulation. The total absence of apoC2 or defects in its structure …
载脂蛋白 C2（APOC2）基因 | MCE - MCE-生物活性分子大师
该基因编码属于载脂蛋白基因家族的脂质结合蛋白。 该蛋白质在血浆中分泌，是极低密度脂蛋白的组成部分。 这种蛋白质激活脂蛋白脂肪酶，水解甘油三酯，从而为细胞提供游离脂肪酸。 该 …
APOC2 apolipoprotein C2 [Homo sapiens (human)] - Gene - NCBI
2024年9月18日 · Mutations in this gene cause hyperlipoproteinemia type IB, characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis. …
APOC2 apolipoprotein C2 [ (human)] - National Center for …
2025年2月8日 · Both common and rare DNA variants of APOC2 gene were found in 10% patients with severe hypertriglyceridemia; Hydrolysis activated by APOC2 was faster compared with …
癌症中载脂蛋白 C2 基因的失调：潜在的代谢脆弱性,Clinical and …
载脂蛋白 C2 (APOC2) 是脂蛋白脂肪酶的激活剂，参与甘油三酯、极低密度脂蛋白和高密度脂蛋白的水解以释放游离脂肪酸 (FA)。 1 FA 氧化已成为癌症生存和生长的重要能量来源。 2癌症 …
ApoC2 deficiency elicits severe hypertriglyceridemia and …
Our study provides a novel ApoC2-deleted mammalian model with severe hypertriglyceridemia that was fully characterized and highlights a potential therapeutic approach for the treatment of …
APOC2 apolipoprotein C2 - NIH Genetic Testing Registry (GTR)
2024年3月5日 · APOC2 apolipoprotein C2 Gene ID: 344, updated on 5-Mar-2024 Gene type: protein coding Also known as: APO-CII; APOC-II. See all available tests in GTR for this gene; …
Apolipoprotein C-II induces EMT to promote gastric cancer
APOC2 promoted GC cell invasion, migration, and proliferation via CD36-mediated PI3K/AKT/mTOR signaling activation. Furthermore, APOC2-CD36 axis upregulated EMT …